-
Do patients with diabetes share in the reduction of cardiovascular (CV) risk factors as much as non-diabetics?
-
Dual antiplatelet therapy with aspirin and clopidogrel has become the standard of care for patients suffering an acute coronary syndrome (ACS). However, there remains a significant incidence of recurrent ACS and mortality even in patients treated with dual antiplatelet therapy.
-
The ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) series of randomized, controlled trials has assessed the role of atorvastatin loading prior to percutaneous coronary intervention (PCI) in both stable and unstable coronary syndromes.
-
-
Folke et al from Copenhagen, Denmark, studied the consequences of automatic external defibrillator (AED) placement in a large metropolitan area.
-
Current recommendations for stroke prophylaxis with warfarin for patients with atrial fibrillation do not take into account the risks of hemorrhage.
-
Most colorectal cancers overexpress cyclo-oxygenase 2 (COX-2). Primary prevention with aspirin (ASA) is associated with reduced risk for colon cancer and colonic adenoma.
-
The second competitive, reversible dipeptidyl peptidase-4 (DPP-4) inhibitor has been approved by the FDA for the treatment type 2 diabetes mellitus.
-
Internet-based self-management resulted in improvements in asthma control and lung function with resultant increases in the number of symptom-free days. However, this did not significantly reduce exacerbation rates.
-